XML 37 R26.htm IDEA: XBRL DOCUMENT v3.10.0.1
Stock-Based Compensation (Tables)
 9 Months Ended
Sep. 30, 2018
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]  
Schedule Of Share Based Compensation Shares Authorized Under Stock Plans Issued And Avaliability
The following table summarizes the number of shares of common stock authorized for use under the Plan, the number of stock-based awards granted (net of expired or cancelled awards) under the Plan and the number of shares of common stock available for the grant of stock-based awards under the Plan: 

Common stock authorized
35,199,000

Stock-based awards, including restricted stock and stock options granted, net of expired or cancelled
(33,861,447
)
Common stock available for grant of stock-based awards as of September 30, 2018
1,337,553
Schedule of Employee Service Share-based Compensation, Allocation of Recognized Period Costs
Total equity-based compensation for the three and nine months ended September 30, 2018 and 2017 is as follows:

 
Three Months Ended September 30,
 
Nine Months Ended September 30,
 
2018
 
2017
 
2018
 
2017
Restricted stock
$
3,937

 
$
3,902

 
$
12,075

 
$
12,540

Stock options
1,168

 
1,005

 
3,265

 
3,140

Total
$
5,105

 
$
4,907

 
$
15,340

 
$
15,680
Schedule Of Cash Proceeds And Intrinsic Values For Stock Options Exercised
Cash proceeds and intrinsic values related to total stock options exercised during the three and nine months ended September 30, 2018 and 2017 are as follows:

 
Three Months Ended September 30,
 
Nine Months Ended September 30,
 
2018
 
2017
 
2018
 
2017
Proceeds from stock options exercised
$
1,686

 
$
5,663

 
$
12,801

 
$
11,312

Intrinsic value of stock options exercised
$
1,258

 
$
1,220

 
$
6,737

 
$
4,729
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Method Used
The following weighted average assumptions were used for stock options granted during the nine months ended September 30, 2018 and 2017:

 
 
2018
 
2017
Volatility
 
25.1% to 27.2%
 
23.0% to 26.4%
Risk free interest rate
 
2.1% to 2.7%
 
1.5% to 2.0%
Expected life in years
 
3.4 to 4.9
 
3.4 to 5.0
Dividend yield
 
1.7%
 
0.0%
Weighted average fair value
 
$6.52
 
$5.94
Schedule of Share-based Compensation, Stock Options, Activity
Activity relating to stock options granted under the Company’s plans and outside the plans during the nine months ended September 30, 2018 is as follows: 

 
 
Number of Shares
 
Weighted Average Exercise Price
 
Weighted Average Remaining Contractual Term
 
Aggregate Intrinsic Value
Outstanding at January 1, 2018
 
2,848,000

 
$
23.87

 
 
 
 

Granted
 
576,000

 
32.40

 
 
 
 

Exercised
 
(581,000
)
 
22.03

 
 
 
 

Forfeited
 
(23,000
)
 
22.59

 
 
 
 

Outstanding at September 30, 2018
 
2,820,000

 
$
26.00

 
4.9 years
 
$
26,128

Exercisable at September 30, 2018
 
1,101,000

 
$
24.72

 
4.0 years
 
$
11,607
Schedule of Nonvested Share Activity
The following table summarizes restricted stock activity during the nine months ended September 30, 2018 and 2017:


 
 
2018
 
2017
 
 
Number of Shares
 
Weighted Average Fair Value at Grant Date
 
Number of Shares
 
Weighted Average Fair Value at Grant Date
Non-vested at January 1,
 
5,873,000

 
$
17.37

 
6,287,000

 
$
17.29

Granted
 
372,000

 
31.47

 
389,000

 
24.92

Vested
 
(294,000
)
 
23.79

 
(320,000
)
 
22.17

Forfeited
 
(71,000
)
 
25.61

 
(51,000
)
 
23.39

Non-vested at September 30,
 
5,880,000

 
$
17.84

 
6,305,000

 
$
17.46